SINCLAIR MICHAEL sold 17.2% of their position (8.49K shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $109.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/8/2022ACC: 0001385508-22-000072
Director10% Owner
Since Sep 2019
-8.49K
Net shares
Net seller
$109.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
8.49K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.69K
Price / share
$12.94
Trade value
$99.48K
% of position
15.6%
6/6/2022
49.22K→41.53K
Common Stock
Direct
Shares
−800.00
Price / share
$12.86
Trade value
$10.29K
% of position
1.9%
6/7/2022
41.53K→40.73K
Total
Net shares
−8.49K
Net value
-$109.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/6/2022 | S · Sale | −7.69K | $12.94 | $99.48K | 15.6% | 49.22K | 41.53K |
| Common Stock Direct | 6/7/2022 | S · Sale | −800.00 | $12.86 | $10.29K | 1.9% | 41.53K | 40.73K |
| Total | −8.49K | -$109.77K | ||||||
Derivative Transactions0
No derivative transactions reported